Bevacizumab
Drug timelines are a Plus or Pro feature.
1343 regulatory and trial events tracked for Bevacizumab, covering 2006-09-08 to 2026-07-15. Get the full timeline:
Most recent: Clinical Trial Update: A Global Study to Evaluate Transarterial Chemoembolization (TACE) in Combination With Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma [Phase 3]